Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Long Bridge Medical is a South San Francisco-based ophthalmic device company focused on developing innovative solutions for complex intraocular lens (IOL) fixation. The company's lead product, LensOne™, is a prosthetic capsular bag designed to restore the anatomic foundation needed for standard IOL implantation in eyes lacking natural capsule support. LensOne has received FDA Breakthrough Device Designation and recently gained Investigational Device Exemption (IDE) clearance to initiate the GOLDEN GATE pivotal clinical trial. By providing a standardized, reproducible tool, the company aims to improve outcomes for patients suffering from conditions like post-surgical aphakia and spontaneous IOL dislocation who are poor candidates for traditional anterior chamber lenses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Long Bridge Medical.